James P Yee

Insider

First SEC filing: July 16, 2014 · Latest: July 16, 2014

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.
Compensation Executive pay disclosed in company proxy statements.

Insider at

CDNA selling July 1, 2019

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 36 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

36 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
July 1, 2019	CDNA	M	19,875	—	—	7,125 Direct	-73.61%	Disposed	(price as of 2026-08-20)
July 1, 2019	CDNA	S 10b5-1	20,000	$35.65	$713,000	42,045 Direct	-32.23%	Disposed	32.5% (price as of 2026-08-20)
July 1, 2019	CDNA	M 10b5-1	19,875	$2.30	$45,712	62,045 Direct	+47.13%	Acquired	1954.3% (price as of 2026-08-20)
June 17, 2019	CDNA	M	20,000	—	—	15,000 Direct	-57.14%	Disposed	(price as of 2026-08-20)
June 17, 2019	CDNA	S 10b5-1	20,000	$37.54	$750,800	42,170 Direct	-32.17%	Disposed	25.9% (price as of 2026-08-20)
June 17, 2019	CDNA	M 10b5-1	20,000	$6.49	$129,800	62,170 Direct	+47.43%	Acquired	628.0% (price as of 2026-08-20)
June 3, 2019	CDNA	F	1,239	$32.80	$40,639	42,170 Direct	-2.85%	Disposed	44.1% (price as of 2026-08-20)
March 12, 2019	CDNA	S 10b5-1	7,598	$35.18	$267,298	43,409 Direct	-14.90%	Disposed	34.3% (price as of 2026-08-20)
March 1, 2019	CDNA	F	3,685	$31.64	$116,593	51,007 Direct	-6.74%	Disposed	49.3% (price as of 2026-08-20)
March 1, 2019	CDNA	A	10,000	—	—	54,692 Direct	+22.38%	Acquired	(price as of 2026-08-20)
Feb. 12, 2019	CDNA	M	3,649	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Feb. 12, 2019	CDNA	M	3,649	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Feb. 12, 2019	CDNA	S 10b5-1	32,500	$23.88	$776,100	44,692 Direct	-42.10%	Disposed	97.9% (price as of 2026-08-20)
Feb. 12, 2019	CDNA	M 10b5-1	3,649	$3.97	$14,487	77,192 Direct	+4.96%	Acquired	1090.2% (price as of 2026-08-20)
Feb. 12, 2019	CDNA	M 10b5-1	3,649	$3.70	$13,501	73,543 Direct	+5.22%	Acquired	1177.0% (price as of 2026-08-20)
Feb. 4, 2019	CDNA	A	16,000	—	—	16,000 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 4, 2019	CDNA	F	2,766	$27.17	$75,152	69,894 Direct	-3.81%	Disposed	73.9% (price as of 2026-08-20)
Feb. 4, 2019	CDNA	A	8,000	—	—	72,660 Direct	+12.37%	Acquired	(price as of 2026-08-20)
Feb. 4, 2019	CDNA	A	8,000	—	—	64,660 Direct	+14.12%	Acquired	(price as of 2026-08-20)
Jan. 28, 2019	CDNA	F	845	$27.46	$23,204	56,660 Direct	-1.47%	Disposed	72.1% (price as of 2026-08-20)
Jan. 22, 2019	CDNA	F	2,139	$25.05	$53,582	57,505 Direct	-3.59%	Disposed	88.6% (price as of 2026-08-20)
June 29, 2018	CDNA	F	3,458	$12.24	$42,326	59,644 Direct	-5.48%	Disposed	286.0% (price as of 2026-08-20)
June 29, 2018	CDNA	A	10,000	—	—	10,000 Direct	—	Acquired	(price as of 2026-08-20)
June 29, 2018	CDNA	A	10,000	—	—	63,102 Direct	+18.83%	Acquired	(price as of 2026-08-20)
June 29, 2018	CDNA	A	10,000	—	—	53,102 Direct	+23.20%	Acquired	(price as of 2026-08-20)
Jan. 29, 2018	CDNA	F	805	$6.25	$5,031	43,102 Direct	-1.83%	Disposed	656.0% (price as of 2026-08-20)
Jan. 22, 2018	CDNA	F	1,691	$6.29	$10,636	43,907 Direct	-3.71%	Disposed	651.2% (price as of 2026-08-20)
Jan. 19, 2018	CDNA	A	20,000	—	—	20,000 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 8, 2017	CDNA	M	29,197	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Dec. 8, 2017	CDNA	S	29,197	$7.00	$204,379	45,598 Direct	-39.04%	Disposed	575.0% (price as of 2026-08-20)
Dec. 8, 2017	CDNA	M	29,197	$3.36	$98,102	74,795 Direct	+64.03%	Acquired	1306.3% (price as of 2026-08-20)
Nov. 9, 2017	CDNA	A	13,359	—	—	13,359 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 8, 2017	CDNA	D	21,897	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-20)
Sept. 1, 2017	CDNA	A	10,000	—	—	10,000 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 17, 2017	CDNA	A	27,000	—	—	27,000 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 17, 2017	CDNA	A	10,000	—	—	45,598 Direct	+28.09%	Acquired	(price as of 2026-08-20)
Oct. 28, 2016	CDNA	A	10,000	—	—	10,000 Direct	—	Acquired	(price as of 2026-08-20)
Jan. 22, 2016	CDNA	A	33,000	—	—	33,000 Direct	—	Acquired	(price as of 2026-08-20)
Jan. 22, 2016	CDNA	A	11,000	—	—	35,598 Direct	+44.72%	Acquired	(price as of 2026-08-20)
March 6, 2015	CDNA	A	35,000	—	—	35,000 Direct	—	Acquired	(price as of 2026-08-20)
March 6, 2015	CDNA	A	10,000	—	—	24,598 Direct	+68.50%	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
July 1, 2019	CDNA	Employee Stock Option (right to buy)	Common Stock (19,875)	$2.30	Feb. 17, 2027	19,875	Disposed
June 17, 2019	CDNA	Employee Stock Option (right to buy)	Common Stock (20,000)	$6.49	March 6, 2025	20,000	Disposed
Feb. 12, 2019	CDNA	Option to Purchase Common Stock	Common Stock (3,649)	$3.97	Aug. 27, 2020	3,649	Disposed
Feb. 12, 2019	CDNA	Option to Purchase Common Stock	Common Stock (3,649)	$3.70	April 8, 2020	3,649	Disposed
Feb. 4, 2019	CDNA	Employee Stock Option (right to buy)	Common Stock (16,000)	$27.17	Feb. 4, 2029	16,000	Acquired
June 29, 2018	CDNA	Employee Stock Option (right to buy)	Common Stock (10,000)	$12.24	June 29, 2028	10,000	Acquired
Jan. 19, 2018	CDNA	Employee Stock Option (right to buy)	Common Stock (20,000)	$6.31	Jan. 19, 2028	20,000	Acquired
Dec. 8, 2017	CDNA	Employee Stock Option (right to buy)	Common Stock (29,197)	$3.36	Jan. 1, 2018	29,197	Disposed
Nov. 9, 2017	CDNA	Option to Purchase Common Stock [F3]	Common Stock (13,359)	—	Nov. 9, 2024	13,359	Acquired
Nov. 8, 2017	CDNA	Option to Purchase Common Stock	Common Stock (21,897)	$12.40	April 8, 2024	21,897	Disposed
Sept. 1, 2017	CDNA	Employee Stock Option (right to buy)	Common Stock (10,000)	$2.80	Sept. 1, 2027	10,000	Acquired
Feb. 17, 2017	CDNA	Employee Stock Option (right to buy)	Common Stock (27,000)	$2.30	Feb. 17, 2027	27,000	Acquired
Oct. 28, 2016	CDNA	Employee Stock Option (right to buy)	Common Stock (10,000)	$3.67	Oct. 28, 2026	10,000	Acquired
Jan. 22, 2016	CDNA	Employee Stock Option (right to buy)	Common Stock (33,000)	$5.27	Jan. 22, 2026	33,000	Acquired
March 6, 2015	CDNA	Employee Stock Option (right to buy)	Common Stock (35,000)	$6.49	March 6, 2025	35,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
July 16, 2014	CDNA	Common Stock	14,598	Direct
July 16, 2014	CDNA	Option to Purchase Common Stock→ Common Stock (14,598)	14,598	Direct
July 16, 2014	CDNA	Option to Purchase Common Stock→ Common Stock (29,197)	29,197	Direct
July 16, 2014	CDNA	Option to Purchase Common Stock→ Common Stock (3,649)	3,649	Direct
July 16, 2014	CDNA	Option to Purchase Common Stock→ Common Stock (3,649)	3,649	Direct
July 16, 2014	CDNA	Option to Purchase Common Stock→ Common Stock (21,897)	21,897	Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CDNA

M.D., Ph.D.(5)Former Chief Medical Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2019	$247,401	—	$652,080	$278,446	—	—	$300	$1,178,227
2017	$382,905	—	—	—	$184,800	—	—	$697,495
2016	$376,620	—	—	—	$112,986	—	—	$634,321

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.